Laboratory Department, The First Affiliated Hospital of Yangtze University, Jing Zhou, Hubei, China.
Laboratory Department, The People's Hospital of Songzi, Jingzhou, Hubei, China.
BMC Infect Dis. 2024 Jun 6;24(1):566. doi: 10.1186/s12879-024-09475-x.
Early and appropriate antibiotic treatment improves the clinical outcome of patients with sepsis. There is an urgent need for rapid identification (ID) and antimicrobial susceptibility testing (AST) of bacteria that cause bloodstream infection (BSI). Rapid ID and AST can be achieved by short-term incubation on solid medium of positive blood cultures using MALDI-TOF mass spectrometry (MS) and the BD M50 system. The purpose of this study is to evaluate the performance of rapid method compared to traditional method.
A total of 124 mono-microbial samples were collected. Positive blood culture samples were short-term incubated on blood agar plates and chocolate agar plates for 5 ∼ 7 h, and the rapid ID and AST were achieved through Zybio EXS2000 MS and BD M50 System, respectively.
Compared with the traditional 24 h culture for ID, this rapid method can shorten the cultivation time to 5 ∼ 7 h. Accurate organism ID was achieved in 90.6% of Gram-positive bacteria (GP), 98.5% of Gram-negative bacteria (GN), and 100% of fungi. The AST resulted in the 98.5% essential agreement (EA) and 97.1% category agreements (CA) in NMIC-413, 99.4% EA and 98.9% CA in PMIC-92, 100% both EA and CA in SMIC-2. Besides, this method can be used for 67.2% (264/393) of culture bottles during routine work. The mean turn-around time (TAT) for obtaining final results by conventional method is approximately 72.6 ± 10.5 h, which is nearly 24 h longer than the rapid method.
The newly described method is expected to provide faster and reliable ID and AST results, making it an important tool for rapid management of blood cultures (BCs). In addition, this rapid method can be used to process most positive blood cultures, enabling patients to receive rapid and effective treatment.
早期和适当的抗生素治疗可改善脓毒症患者的临床预后。迫切需要快速鉴定(ID)和药敏试验(AST)引起血流感染(BSI)的细菌。通过使用 MALDI-TOF 质谱(MS)和 BD M50 系统对阳性血培养物进行短期孵育,可以实现快速 ID 和 AST。本研究的目的是评估与传统方法相比的快速方法的性能。
共收集了 124 个单微生物样本。阳性血培养物在血琼脂平板和巧克力琼脂平板上短时间孵育 5-7 小时,通过 Zybio EXS2000 MS 和 BD M50 系统分别实现快速 ID 和 AST。
与传统的 24 小时培养物 ID 相比,这种快速方法可以将培养时间缩短至 5-7 小时。90.6%的革兰氏阳性菌(GP)、98.5%的革兰氏阴性菌(GN)和 100%的真菌实现了准确的生物体 ID。AST 在 NMIC-413 中产生了 98.5%的基本一致(EA)和 97.1%的类别一致(CA),在 PMIC-92 中产生了 99.4%的 EA 和 98.9%的 CA,SMIC-2 中达到了 100%的 EA 和 CA。此外,该方法可用于日常工作中 67.2%(264/393)的培养瓶。常规方法获得最终结果的平均周转时间(TAT)约为 72.6±10.5 小时,比快速方法长近 24 小时。
新描述的方法有望提供更快和可靠的 ID 和 AST 结果,使其成为快速管理血培养物(BC)的重要工具。此外,这种快速方法可用于处理大多数阳性血培养物,使患者能够获得快速有效的治疗。